[go: up one dir, main page]

FI906408L - Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI906408L
FI906408L FI906408A FI906408A FI906408L FI 906408 L FI906408 L FI 906408L FI 906408 A FI906408 A FI 906408A FI 906408 A FI906408 A FI 906408A FI 906408 L FI906408 L FI 906408L
Authority
FI
Finland
Prior art keywords
aminopyrimidine
preparation
therapeutically useful
carboxamide derivatives
carboxamide
Prior art date
Application number
FI906408A
Other languages
English (en)
Swedish (sv)
Other versions
FI94953B (fi
FI906408A0 (fi
FI94953C (fi
Inventor
Pascal George
Philippe Manoury
Jacques Froissant
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI906408A0 publication Critical patent/FI906408A0/fi
Publication of FI906408L publication Critical patent/FI906408L/fi
Publication of FI94953B publication Critical patent/FI94953B/fi
Application granted granted Critical
Publication of FI94953C publication Critical patent/FI94953C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
FI906408A 1989-12-28 1990-12-27 Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi FI94953C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8917304A FR2656609B1 (fr) 1989-12-28 1989-12-28 Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR8917304 1989-12-28

Publications (4)

Publication Number Publication Date
FI906408A0 FI906408A0 (fi) 1990-12-27
FI906408L true FI906408L (fi) 1991-06-29
FI94953B FI94953B (fi) 1995-08-15
FI94953C FI94953C (fi) 1995-11-27

Family

ID=9389050

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906408A FI94953C (fi) 1989-12-28 1990-12-27 Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (1) US5164397A (fi)
EP (1) EP0435749B1 (fi)
JP (1) JP2515434B2 (fi)
KR (1) KR910011841A (fi)
AT (1) ATE132859T1 (fi)
AU (1) AU630777B2 (fi)
CA (1) CA2033303A1 (fi)
CS (1) CS405291A3 (fi)
DE (1) DE69024778T2 (fi)
DK (1) DK0435749T3 (fi)
ES (1) ES2084015T3 (fi)
FI (1) FI94953C (fi)
FR (1) FR2656609B1 (fi)
GR (1) GR3019508T3 (fi)
HU (1) HU207515B (fi)
IE (1) IE72954B1 (fi)
IL (1) IL96815A (fi)
MX (1) MX172953B (fi)
NO (1) NO178968C (fi)
NZ (1) NZ236605A (fi)
PT (1) PT96381B (fi)
ZA (1) ZA9010412B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
CZ279305B6 (cs) * 1992-01-24 1995-04-12 Lonza A.G. Kyseliny 2-halogen pyrimidin-4-karboxylové, způsob jejich přípravy a jejich použití pro přípravu derivátů substituovaných pyrimidinů-4-karboxylový ch kyselin
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
FR2699171B1 (fr) * 1992-12-14 1995-02-03 Synthelabo Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2693195B1 (fr) * 1992-07-03 1994-09-23 Synthelabo Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
ES2073951T3 (es) * 1992-07-03 1995-08-16 Synthelabo Derivados de 2-amino-n-(((4-(aminocarbonil)pirimidin-2-il)amino)alquil)pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
FR2703355B1 (fr) * 1993-03-29 1995-05-05 Synthelabo Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2705344B1 (fr) * 1993-05-17 1995-06-30 Synthelabo Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
FR2744722B1 (fr) * 1996-02-14 1998-03-13 Synthelabo Devires de 2-((3-(piperazin-1-yl)propyl)amino)pyrimidine-4- carboxamide et leur application en therapeutique
TW593290B (en) * 1996-05-10 2004-06-21 Janssen Pharmaceutica Nv Alkylaminobenzothiazole and -benzoxazole derivatives
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
AR078793A1 (es) 2009-10-27 2011-12-07 Orion Corp Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
CA2872883A1 (en) * 2012-05-09 2013-11-14 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787126A (fr) * 1971-08-04 1973-02-05 Byk Gulden Lomberg Chem Fab Pyrimidines substituees, procedes de preparation de ces composes et medicaments contenant lesdits composes
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
IL96815A (en) 1996-06-18
FR2656609B1 (fr) 1992-03-27
NZ236605A (en) 1992-08-26
FI94953B (fi) 1995-08-15
JP2515434B2 (ja) 1996-07-10
ZA9010412B (en) 1991-10-30
IE904719A1 (en) 1991-07-17
JPH04139173A (ja) 1992-05-13
KR910011841A (ko) 1991-08-07
FR2656609A1 (fr) 1991-07-05
CA2033303A1 (en) 1991-06-29
NO905591L (no) 1991-07-01
AU6845190A (en) 1991-07-04
NO905591D0 (no) 1990-12-27
DK0435749T3 (da) 1996-05-20
CS405291A3 (en) 1992-04-15
PT96381A (pt) 1991-10-15
FI906408A0 (fi) 1990-12-27
HU207515B (en) 1993-04-28
DE69024778T2 (de) 1996-09-19
US5164397A (en) 1992-11-17
IL96815A0 (en) 1991-09-16
IE72954B1 (en) 1997-05-07
ATE132859T1 (de) 1996-01-15
AU630777B2 (en) 1992-11-05
FI94953C (fi) 1995-11-27
DE69024778D1 (de) 1996-02-22
EP0435749B1 (fr) 1996-01-10
GR3019508T3 (en) 1996-07-31
EP0435749A1 (fr) 1991-07-03
HUT56092A (en) 1991-07-29
NO178968B (no) 1996-04-01
ES2084015T3 (es) 1996-05-01
MX172953B (es) 1994-01-25
NO178968C (no) 1996-07-10
PT96381B (pt) 1998-06-30

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI875660L (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI881180L (fi) Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
FI914905L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI922345L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-substituoitujen pyrrolidiinijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI884910A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SYNTHELABO

BB Publication of examined application
MM Patent lapsed

Owner name: SYNTHELABO